Charles Zhu
Stock Analyst at LifeSci Capital
(1.71)
# 1558
Out of 5,255 analysts
26
Total ratings
55.00%
Success rate
21.98%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Repare Therapeutics | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Dec 13, 2024 | |
Tango Therapeutics | Maintains: Buy | 18 8 | 3.14 | 154.78% | 3 | Nov 7, 2024 | |
Macrogenics | Upgrades: Buy | 12 | 3 | 300% | 4 | Nov 7, 2023 | |
Merus | Maintains: Strong Buy | 46 48 | 41.86 | 14.67% | 6 | Aug 8, 2023 | |
Nuvalent | Initiates Coverage On: Buy | 56 | 87.56 | -36.04% | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 22 | 4.51 | 387.8% | 1 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 26 | 9.97 | 160.78% | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 | 23.93 | 33.72% | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 14 | 14.9 | -6.04% | 2 | May 5, 2022 |